Investigación Biomédica para el Desarrollo de Fármacos S.A. de C.V.

Zapopan, Jalisco C.P. 45070

1 studies enrolling now · 6 studies all time

What they study most

Cancer, Systemic Lupus Erythematosus, Ulcerative Colitis

Studies at this site

• Pan Tumor Rollover Study — Recruiting now
• A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis — Completed
• An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1) — Completed
• A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) — Completed
• A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) — Stopped early
• A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus — Stopped early